Loading data
DCTHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 85.23 m USD | 37.21 m USD | 2.07 m USD | 2.72 m USD | 3.56 m USD |
| Cost of revenue | 11.8 m USD | 6.19 m USD | 635 k USD | 686 k USD | 671 k USD |
| Gross profit | 73.43 m USD | 31.02 m USD | 1.43 m USD | 2.03 m USD | 2.88 m USD |
| Research and development expense | 29.25 m USD | 13.87 m USD | 17.5 m USD | 18.58 m USD | 13.78 m USD |
| Selling, general and administrative expense | 43.53 m USD | 29.55 m USD | 22.11 m USD | 17.3 m USD | 13.64 m USD |
| Operating profit | 660 k USD | -12.41 m USD | -38.18 m USD | -33.85 m USD | -24.53 m USD |
| Profit before tax | 3.51 m USD | -26.39 m USD | -47.68 m USD | -36.51 m USD | -25.65 m USD |
| Income tax expense | 810 k USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | 2.7 m USD | -26.39 m USD | -47.68 m USD | -36.51 m USD | -25.65 m USD |
| Net income attributable to common shareholders | — | — | — | — | -25.65 m USD |
| Basic earnings per share | 0.08 USD/share | -0.93 USD/share | -2.94 USD/share | -4.12 USD/share | -3.59 USD/share |
| Diluted earnings per share | 0.07 USD/share | -0.93 USD/share | -2.94 USD/share | -4.12 USD/share | -3.59 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.